Technical Analysis for EVAX - Evaxion Biotech A/S

Grade Last Price % Change Price Change
F 3.20 6.67% 0.20
EVAX closed up 6.67 percent on Thursday, March 28, 2024, on 2 percent of normal volume.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Up

Date Alert Name Type % Chg
Crossed Above 20 DMA Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Fell Below 20 DMA Bearish 6.67%
Bollinger Band Squeeze Range Contraction 6.67%
BB Squeeze Started Range Contraction 6.67%
Crossed Above 20 DMA Bullish 2.24%
20 DMA Resistance Bearish 3.23%
Outside Day Range Expansion 3.23%
Narrow Range Bar Range Contraction 4.92%
Wide Bands Range Expansion 4.92%

   Recent Intraday Alerts

Alert Time
Up 5% about 16 hours ago
Rose Above Previous Day's High about 17 hours ago
Possible Inside Day about 18 hours ago
60 Minute Opening Range Breakout about 19 hours ago
Up 3% about 19 hours ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Evaxion Biotech A/S Description

Evaxion Biotech A/S, a clinical-stage artificial intelligence-immunology platform company, identifies and develops novel immunotherapies for the treatment of various cancers, bacterial diseases, and viral infections. The company develops therapies using PIONEER, an immuno-oncology platform; EDEN, a bacterial disease platform; and RAVENTM, a viral disease platform. It develops EVX-01, a novel liposomal, peptide-based cancer immunotherapy that is in clinical Phase I/IIa trial for indications, such as metastatic and/or unresectable melanoma, non-small cell lung cancer, and bladder cancer; EVX-02, a novel, DNA-based cancer immunotherapy that is in Phase I/IIa trial designed to induce a therapeutic immune response in the adjuvant setting in patients with resected melanoma; and EVX-03, a DNA-based neoepitope immunotherapy, which is in late pre-clinical development for the treatment of various cancers, as well as EVX-B1, a multi-component subunit vaccine for the prevention of S. aureus induced skin and soft tissue infections in patients undergoing hernia surgery. The company has collaboration agreements with National Center for Cancer Immune Therapy (CCIT-DK) at Herlev Hospital, Department of Health Technology at Danish Technical University, Center for Genomic Medicine at University Hospital Copenhagen, and the Center for Vaccine Research at SSI for the development and Phase 1/2a clinical trial of its EVX-01 product candidate. Evaxion Biotech A/S was founded in 2008 and is headquartered in Copenhagen, Denmark.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biotechnology Cancer Clinical Medicine Artificial Intelligence Immunotherapy Surgery Cancer Immunotherapy Genomics Immunotherapies Non Small Cell Lung Cancer Medical Genetics Melanoma Vaccination Bladder Cancer Viral Disease Bacterial Disease Cancer Vaccine Treatment Of Various Cancers Viral Infections Hernia

Is EVAX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 18.5
52 Week Low 2.8243
Average Volume 823,686
200-Day Moving Average 7.99
50-Day Moving Average 4.18
20-Day Moving Average 3.07
10-Day Moving Average 3.07
Average True Range 0.31
RSI (14) 43.82
ADX 12.47
+DI 18.73
-DI 20.62
Chandelier Exit (Long, 3 ATRs) 2.86
Chandelier Exit (Short, 3 ATRs) 3.76
Upper Bollinger Bands 3.28
Lower Bollinger Band 2.86
Percent B (%b) 0.81
BandWidth 13.74
MACD Line -0.29
MACD Signal Line -0.39
MACD Histogram 0.1024
Fundamentals Value
Market Cap 15.4 Million
Num Shares 4.81 Million
EPS -9.50
Price-to-Earnings (P/E) Ratio -0.34
Price-to-Sales 0.00
Price-to-Book 7.59
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.50
Resistance 3 (R3) 3.47 3.33 3.45
Resistance 2 (R2) 3.33 3.26 3.35 3.43
Resistance 1 (R1) 3.27 3.21 3.30 3.30 3.42
Pivot Point 3.13 3.13 3.15 3.15 3.13
Support 1 (S1) 3.07 3.06 3.10 3.10 2.98
Support 2 (S2) 2.93 3.01 2.95 2.97
Support 3 (S3) 2.87 2.93 2.95
Support 4 (S4) 2.90